Executive summary

Three-sentence thesis: CCC operates the dominant two-sided digital network for U.S. automotive-insurance claims and collision repair — 27 of the top 30 auto insurers, 30,000+ repair facilities, 6,000+ parts suppliers, 14 of 15 top OEMs, and ~900,000 registered users processing $200B+ of transactions annually — a business with a 99% software gross-dollar-retention rate that is among the stickiest in all of software. The stock has fallen ~48% in a year and screens "expensive" on GAAP P/E only because reported earnings are crushed by ~$175M of stock-based compensation and $150M of D&A (much of it from the January 2025 EvolutionIQ AI acquisition), masking $252M of trailing free cash flow and a 42% Adjusted EBITDA margin. At $4.66 the business trades at ~8.6x forward EV/EBITDA and ~11x P/FCF (an 8.9% FCF yield) — genuinely cheap for a wide-moat, recurring-revenue compounder — but real SBC of ~16% of revenue, 2.7x net leverage, and a still-loss-making AI bet keep my margin of safety thin, so this is a high-quality WAIT with a near-term accumulate trigger rather than an outright buy today.

Key metrics dashboard

Verdict

WAIT — accumulate below ~$4.25; strong buy below ~$3.55. Blended intrinsic value ~$5.30/share; at $4.66 the margin of safety is only ~12%, below my 20% threshold for a leveraged business with a thin-cover AI growth bet. This is a watch-list name I want to own at the right price, not a pass.

1. Opportunity identification (Klarman): why is this cheap?

A wide-moat SaaS network should not trade at 11x FCF. The mispricing has identifiable, non-permanent sources:

1. GAAP optics. Post-SPAC, CCC carries $175M annual SBC (16% of revenue) and ~$150M D&A, including acquisition-amortization. GAAP net income was $1.7M in 2025, so the headline P/E is ~1,700x. Screens flag it as "expensive" while it is cheap on cash. (non-permanent — SBC trends down as the SPAC-era grants vest and EvolutionIQ integration normalizes.)
2. The EvolutionIQ overhang. The $674.3M January 2025 acquisition of an AI disability/injury-claims company added only ~4% of revenue but a $89.2M pretax loss in 2025 (incl. $56.7M SBC, $19.1M amortization). The market is treating it as value-destructive dilution funded with debt and stock. (time will tell — it is a real bet, but it is small relative to the core.)
3. Leverage + buyback timing. Net leverage rose to 2.7x to fund the deal and aggressive buybacks ($1.1B returned over 2.5 years, including a $300M ASR at $7.22 in Dec 2025 — now underwater at $4.66). Buying back at the high and the stock then halving looks like poor timing. (real criticism — but it shrinks the share count permanently.)
4. Claim-volume cyclicality fear. Industry claim volumes fell 6% YoY in Q4 2025 (3% normalized). The market fears a structurally shrinking pool of auto claims (safer cars, ADAS). (partly offsetting — fewer but more complex/expensive claims, and CCC is shifting clients to subscriptions to dampen volume sensitivity.)
5. Small-cap neglect + lost sponsor sponsorship. The legacy PE sponsors (Advent, Oak Hill) have fully exited; only Principal Global (6.21%, passive) remains a 5% holder. The forced-seller overhang that depressed the SPAC is gone, but so is sell-side promotion. (neglect = opportunity.)

Klarman test passed: I can explain why it is cheap — GAAP optics, a misunderstood AI acquisition, leverage taken on near the price peak, and small-cap neglect. None is permanent value destruction. Chuck Akre increasing his position +27% in Q1 2026 corroborates the variant view (used only as a sanity check, not a thesis input).

2. Business model in one sentence

CCC sells mission-critical, embedded SaaS subscriptions that sit on the operating rails between auto insurers, collision-repair shops, parts suppliers, and automakers — so that every party in a U.S. auto-physical-damage claim must transact through CCC's network to estimate, route, and settle the claim.

That is a sentence a 12-year-old can grasp: "When your car gets dinged and the insurer pays the body shop, the paperwork and the money go through CCC's software."

3. Risk analysis (inversion first)

"All I want to know is where I'm going to die, so I'll never go there." — Munger

3.1 How could this lose 50%+ permanently?

3.2 The bear case, stated better than the bears

CCC is a no-growth toll booth on a shrinking road. Auto-physical-damage claims are a structurally declining pool as cars get safer, and CCC's 9% growth is borrowed from a one-time subscription conversion and a debt-funded AI acquisition that loses $89M a year. Strip out $175M of stock comp that management pretends is free, and "true" owner earnings are barely $80–165M — meaning the stock at a $4.1B enterprise value is paying 25–50x real earnings for a low-single-digit organic grower with 2.7x leverage, run by a board that just torched $300M buying its own stock at $7.22 right before it fell to $4.66.

If I cannot rebut that paragraph, I should not buy. My rebuttals: (a) claim value (severity) is rising even as count falls, and CCC monetizes complexity; (b) 99% GDR and 106%+ NDR are observed facts, not hope — customers are not leaving and are buying more; (c) SBC is real but trending down as SPAC grants roll off, and the share count fell from 642M to 607M despite SBC, proving buybacks more than offset dilution; (d) emerging AI solutions (~10% of revenue) grew >70% YoY, a genuine second growth engine. The rebuttals are credible but not airtight on point (a) and on (d)'s durability — hence WAIT, not BUY.

3.3 Non-price sell triggers (defined before buying)

1. GDR falls below 96% for two consecutive quarters (moat erosion — the single most important leading indicator).
2. NDR falls below 100% (the upsell engine has stalled; pricing power gone).
3. Net leverage exceeds 3.5x without a clear EBITDA-driven path back below 3x.
4. EvolutionIQ goodwill impairment > $200M (confirms capital-allocation failure).
5. CEO Githesh Ramamurthy sells > 20% of his holding absent estate/diversification disclosure.

4. Financial analysis

4.1 Five-year income statement ($M)

*2021 figures distorted by SPAC-merger SBC and warrant remeasurement. Revenue CAGR 2021→2025 = 11.3%.

Reading: The GAAP line is noise. The signal is steady ~10–12% revenue growth, gross margins consistently 72–76%, and Adjusted EBITDA compounding from $216M (2022) to $436M (2025) — a 26% Adjusted-EBITDA CAGR with margin expanding to 41–42%.

4.2 Free cash flow ($M)

FCF compounded from $89M to $254M (30% CAGR). FCF conversion of Adjusted EBITDA is ~58%, a reasonable level for a leveraged SaaS with meaningful cash taxes and interest.

4.3 The SBC question (the crux of the whole thesis)

Reported FCF of $252M adds back zero penalty for $175M of SBC. SBC is non-cash but economically real — it dilutes owners. The honest test: does the share count grow? It does not: shares fell from 642M (2022) to 607M (Q1 2026), because buybacks ($1.1B over 2.5 years) more than offset SBC-driven issuance. So the cash cost of neutralizing SBC is buried in financing cash flow, not operating FCF.

To avoid double-counting, I value the business three ways and weight them:

• Optimistic (FCF as reported, $252M): assumes SBC normalizes and buybacks keep the count flat for free. DCF base ≈ $5.59/sh.
• Conservative (owner earnings ≈ FCF − ~60% of SBC ≈ $165M): treats most SBC as a real recurring cost. DCF base ≈ $2.92/sh.
• Cash-EBITDA cross-check (EBITDA − SBC ≈ $306M at 11–13x): ≈ $3.41–4.42/sh.

The truth lies in the upper-middle: SBC is high now but falling as a % of revenue (262→175→trending lower per management), and the demonstrated share-count discipline argues against the full haircut.

4.4 Returns on capital

The reported ROIC understates economics because $1.96B goodwill + $0.99B intangibles bloat the capital base. On a tangible basis the core software business is nearly capital-free — incremental revenue carries 70%+ gross margins and minimal incremental capital, which is precisely why incremental FCF compounds so fast. The capital-allocation question is whether management deploys that FCF well (buybacks at $7.22 say "not always").

4.5 Valuation trinity

1. Liquidation / asset floor: Negative. Tangible book is deeply negative (retained earnings −$1.78B; goodwill $1.96B + intangibles $0.99B vs. $1.72B equity). There is no Graham floor — this is a pure going-concern, cash-flow business. NCAV is sharply negative. This raises the bar: there is no balance-sheet safety net, so the entire margin of safety must come from cash-flow conservatism.

2. Going-concern DCF (WACC 10%, 5-yr stage-1 + 5-yr fade + terminal):

3. Private market value: Vertical-SaaS networks with 99% GDR are prized strategic assets. Comparable take-private/strategic multiples for sticky vertical SaaS run 12–16x EBITDA. At 13x 2026e Adjusted EBITDA ($481M) = $6.25B EV → ~$8.16/sh equity. A financial sponsor could re-lever and pay a premium; this is a credible LBO/strategic target given the clean cap table and 58% FCF conversion. PMV ≈ $7–8/sh — a meaningful upside optionality.

4. Relative / multiple cross-check:

Blended intrinsic value (30% reported-FCF DCF, 25% conservative-OE DCF, 25% EV/EBITDA, 20% P/FCF): ~$5.30/share.

4.6 Margin of safety

The spread (−37% to +32%) is the whole story: how you treat SBC determines whether CCC is cheap or dear. At 12% blended MOS, with no balance-sheet floor and 2.7x leverage, I require more cushion. Required MOS without a hard catalyst = 30%; with the soft catalysts present (buybacks, AI ramp), I will accept 20%, implying an accumulate price of ~$4.25 and a strong-buy at ~$3.55.

5. Moat analysis

5.1 Moat sources, measured

5.2 Durability test — wider or narrower in 10 years?

Verdict: moat is WIDE and most likely STABLE-to-WIDENING. The same AI wave the market fears is, on balance, CCC's best moat-deepener because it monetizes the one thing rivals cannot copy — the network's data and embedded workflows. The genuine open question is claim-volume secular decline; that caps the width of any "widening" claim but does not breach the moat. I assess the moat as wide today and wide in 10 years.

6. Management & incentives (Munger)

• CEO Githesh Ramamurthy — long-tenured chairman/CEO who built the modern CCC; owns 36,568,913 shares (6.10%), worth ~$170M at $4.66 — real, founder-grade skin in the game. He has committed to exercise options only via net/cashless mechanics, limiting market overhang.
• Insiders (11 officers/directors): 6.57% combined. Aligned.
• Cap table is clean: legacy PE sponsors (Advent, Oak Hill) have fully exited; only Principal Global (6.21%, passive index) remains a 5%+ holder. The historical sponsor overhang is gone.
• Capital allocation — mixed: $1.1B returned via buybacks over 2.5 years has shrunk the share count from 642M to 607M (good, accretive on a per-share basis), but the $300M December-2025 ASR at $7.22 is already ~36% underwater, and the $674M EvolutionIQ deal is unproven and loss-making. The instinct to return cash is right; the timing and the M&A discipline are questionable. Management states buybacks remain the near-term priority "particularly at current levels" — at $4.66 that is now genuinely value-accretive.
• Incentive structure: compensation tied to short- and long-term incentive plans with performance RSUs linked to total shareholder return — directionally aligned, though heavy SBC is the cost.

Munger's test ("if I had these incentives, what would I do?"): A 6%-owner founder should maximize per-share intrinsic value — which argues for heavy buybacks at $4.66 and no more dilutive M&A. Management's stated plan matches. Net assessment: good operator, average-to-good capital allocator, well-aligned.

7. Catalysts

This is a catalyst-rich situation, which justifies the lower (20%) MOS threshold — but none is a hard, dated event, so I will not pay up before a 20% cushion exists.

8. Megatrend & macro overlay

• AI/automation: Net beneficiary — the network's proprietary data is the fuel for defensible AI; +1.
• Demographics / driving: Neutral-to-slightly-negative (fewer, safer cars long-term) but offset by claim severity; 0.
• American protectionism / China: Minimal direct tariff exposure; small China operations (CCC Cayman) with a minority investor — a modest complexity, not a thesis risk; 0.
• Fiscal/rates (Dalio): 2.7x leverage on a floating-rate Term B loan is the real macro sensitivity — higher-for-longer rates pressure FCF. Hedged in part. The U.S. is late-cycle on debt, but CCC's demand (auto claims) is non-discretionary and counter-cyclical-ish (claims happen regardless of GDP). Net: monitor leverage; not a fortress, but not fragile.

Tier 2 "Resilient" — normal position sizing when valuation permits.

9. Decision synthesis

Expected-return tree (2-year horizon)

A +17.8% two-year expected return is positive but not exceptional for the risk taken; the asymmetry improves materially at ~$4.00 (where the same tree yields ~+37%).

Position sizing

At $4.66: 0% (WAIT). At ≤$4.25 (20% MOS): half position ~1.5%. At ≤$3.55 (33% MOS, strong buy): full position ~3% given wide moat + catalysts but offset by leverage and SBC.

Price ladder

Monitoring metrics

10. Conclusion

CCC is a genuinely wide-moat, founder-led vertical-SaaS network with best-in-class 99% gross retention and a clean post-PE cap table, throwing off ~$252M of free cash flow that the market is misjudging because GAAP earnings are buried under stock comp and acquisition amortization. It is cheap on cash and not cheap on conservatively-defined owner earnings — and at $4.66 the ~12% blended margin of safety is too thin for a 2.7x-levered business with no balance-sheet floor and an unproven AI acquisition.

This is exactly the kind of business to own — at the right price. I want it at ~$4.25 (accumulate) and would back up the truck below ~$3.55. Until then: WAIT, watch GDR/NDR and leverage, and let Mr. Market's GAAP confusion hand me a better entry.

+-----------------------------------------------------------------+
|                     INVESTMENT RECOMMENDATION                   |
+-----------------------------------------------------------------+
| Company: CCC Intelligent Solutions      Ticker: CCC            |
| Current Price: $4.66        Date: 2026-06-06                   |
+-----------------------------------------------------------------+
| INTRINSIC VALUE (blended): $5.30   MARGIN OF SAFETY: 12%       |
+-----------------------------------------------------------------+
| RECOMMENDATION:  [ ] BUY  [ ] HOLD  [ ] SELL  [X] WAIT        |
+-----------------------------------------------------------------+
| STRONG BUY:   $3.55   ACCUMULATE: $4.25   FAIR VALUE: $5.30   |
| TAKE PROFITS: $6.40   SELL:       $7.95                        |
+-----------------------------------------------------------------+
| POSITION SIZE: 0% now -> 1.5% at $4.25 -> 3% at $3.55         |
| CATALYST: Buybacks at trough + AI emerging-solutions ramp     |
| PRIMARY RISK: Structural claim-volume decline + SBC dilution   |
| SELL TRIGGER: GDR < 96% (2 qtrs) or net leverage > 3.5x       |
+-----------------------------------------------------------------+

Appendix: sources

All financial figures traced to primary SEC filings or company-reported MCP data. No analyst reports or price targets used as inputs. Chuck Akre's Q1 2026 +27% position increase referenced as a corroborating sanity check only, not a valuation input.